PharmaSGP Holding SE (PSG) — Cash Flow-to-Debt Ratio
PharmaSGP Holding SE (PSG) has a Cash Flow-to-Debt Ratio of 0.05x as of March 2025, meaning its operating cash flow of €4.22 Million could theoretically repay 0% of its total liabilities (€81.51 Million) in one year. See PharmaSGP Holding SE (PSG) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
PharmaSGP Holding SE Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for PharmaSGP Holding SE across 10 annual periods. For the full cash flow conversion analysis, see PharmaSGP Holding SE (PSG) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for PharmaSGP Holding SE (2014–2024)
Year-by-year debt coverage analysis for PharmaSGP Holding SE. Check earnings quality score of PharmaSGP Holding SE to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.30x | €24.88 Million | €82.31 Million | ▲ +3.9% |
| 2023 | 0.29x | €26.64 Million | €91.55 Million | ▲ +15.4% |
| 2022 | 0.25x | €24.71 Million | €98.01 Million | ▲ +91.7% |
| 2021 | 0.13x | €12.24 Million | €93.06 Million | ▼ -88.6% |
| 2020 | 1.15x | €15.46 Million | €13.44 Million | ▼ -46.8% |
| 2019 | 2.16x | €17.63 Million | €8.16 Million | ▲ +234.8% |
| 2017 | 0.65x | €14.25 Million | €22.09 Million | ▲ +308.7% |
| 2016 | 0.16x | €3.55 Million | €22.47 Million | ▼ -65.0% |
| 2015 | 0.45x | €10.59 Million | €23.46 Million | ▲ +68.0% |
| 2014 | 0.27x | €5.41 Million | €20.13 Million | — |